Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Lexington, Kentucky 40536


The hypothesis of this study is that the addition of NovoTTF-100A System treatment to salvage chemotherapy will significantly increase time to treatment failure in the brain of small cell lung cancer patients.


Inclusion Criteria: - Histologically confirmed small cell lung cancer histology with CNS metastases - Parenchymal disease, ten or less lesions, and supratentorial - PS 70% or greater - Prior CNS radiotherapy. - No previous or currently active second malignancy - Age > 22 years. - Life expectancy of ≥ 3 months. Exclusion Criteria: - Significant liver function impairment - AST or ALT > 3 times the upper limit of normal; Total bilirubin > upper limit of normal. - Significant renal impairment (serum creatinine > 1.7 mg/dL). - Coagulopathy (as evidenced by PT or APTT >1.5 times in control patients not undergoing anticoagulation).Thrombocytopenia (platelet count < 100 x 103/μL). - Neutropenia (absolute neutrophil count < 1 x 103/μL). - Anemia (Hb < 10 g/L). - Severe acute infection. Serious non-healing wound or ulcer on scalp - Significant co-morbidities within 4 weeks prior to enrollment. - Implanted pacemaker, defibrillator or deep brain stimulator, or documented clinically significant arrhythmias. - Active implanted medical device (e.g. deep brain stimulators, spinal cord stimulators, vagus nerve stimulators, pacemakers, defibrillators, and programmable shunts). - Skull defect (e.g. missing bone with no replacement). - Shunt - Bullet fragments - Evidence of increased intracranial pressure (midline shift > 5mm, clinically significant papilledema, vomiting and nausea or reduced level of consciousness). - Sensitivity to conductive hydrogels. - Pregnant or lactating women



Primary Contact:

Principal Investigator
John L Villano, MD, PhD
Lucille P. Markey Cancer Center at University of Kentucky

Backup Contact:


Location Contact:

Lexington, Kentucky 40536
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.